EOLS vs LNC · rev $157.2M vs P/E 4.9, rev $9.85B
Evolus Inc (EOLS) versus Lincoln National Corporation (LNC) — a side-by-side from cached financials, not a winner call.
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
Lincoln National Corporation (LNC) is a insurance - life company listed on US.
Latest reported EOLS revenue for 2026-06-30 was $157.2M. Net income was -$18.7M. EOLS currently screens at market cap $597.0M.
Latest reported LNC revenue for 2026-06-30 was $9.85B. Net income was $1.16B. Revenue was up 85.6% from 2026-03-31 to 2026-06-30. LNC currently screens at market cap $5.94B and trailing P/E 4.9.
EOLS currently screens at market cap $597.0M. LNC currently screens at market cap $5.94B and trailing P/E 4.9.
Not investment advice. Open the EOLS and LNC stock pages for the full models.
Not investment advice.